What is Galmed Pharmaceuticals Ltd.'s Market Cap?

Galmed Pharmaceuticals Ltd.'s Market Cap is $3.8M, based on as-reported figures from SEC (XBRL) filings.

What is Galmed Pharmaceuticals Ltd.'s Enterprise Value?

Galmed Pharmaceuticals Ltd.'s Enterprise Value is -$4.9M, based on as-reported figures from SEC (XBRL) filings.

What is Galmed Pharmaceuticals Ltd.'s Net Income (TTM)?

Galmed Pharmaceuticals Ltd.'s Net Income (TTM) is -$11.3M, based on as-reported figures from SEC (XBRL) filings.

What is Galmed Pharmaceuticals Ltd.'s Diluted EPS (TTM)?

Galmed Pharmaceuticals Ltd.'s Diluted EPS (TTM) is -11.33, based on as-reported figures from SEC (XBRL) filings.

What is Galmed Pharmaceuticals Ltd.'s Net Debt?

Galmed Pharmaceuticals Ltd.'s Net Debt is -$8.8M, based on as-reported figures from SEC (XBRL) filings.

Galmed Pharmaceuticals Ltd. (GLMD) Financial Statements

Galmed Pharmaceuticals Ltd.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG005ZD02V2

XNAS · usd

3.83▼ 0.05 (-1.42%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close3.88

Day's Range3.74 – 3.96

52-Week Range0.41 – 5.45

Volume14.6K

Avg Volume187.5K

Share Statistics

Shares Outstanding

Employees6

ExchangeXNAS

Listed2014-03-13

Share count as of June 30, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Galmed Pharmaceuticals Ltd. (GLMD)

What is Galmed Pharmaceuticals Ltd.'s Market Cap?: Galmed Pharmaceuticals Ltd.'s Market Cap is $3.8M, based on as-reported figures from SEC (XBRL) filings.
What is Galmed Pharmaceuticals Ltd.'s Enterprise Value?: Galmed Pharmaceuticals Ltd.'s Enterprise Value is -$4.9M, based on as-reported figures from SEC (XBRL) filings.
What is Galmed Pharmaceuticals Ltd.'s Net Income (TTM)?: Galmed Pharmaceuticals Ltd.'s Net Income (TTM) is -$11.3M, based on as-reported figures from SEC (XBRL) filings.
What is Galmed Pharmaceuticals Ltd.'s Diluted EPS (TTM)?: Galmed Pharmaceuticals Ltd.'s Diluted EPS (TTM) is -11.33, based on as-reported figures from SEC (XBRL) filings.
What is Galmed Pharmaceuticals Ltd.'s Net Debt?: Galmed Pharmaceuticals Ltd.'s Net Debt is -$8.8M, based on as-reported figures from SEC (XBRL) filings.